Cantourage Group SE (XTER:HIGH) Net Margin %: 4.37% (As of Jun. 2025)


XTER:HIGH Cantourage Group SE XTER:HIGH
22 GF Score
Price €6.04
! 4 Warning Signs
View Full Analysis

What is Cantourage Group SE Net Margin %?

Cantourage Group SE XTER:HIGH -4.13% 22 Net Margin % is 4.37% as of Jun. 2025. GuruFocus rates XTER:HIGH with a GF Score™ of 22/100. The stock has 4 warning signs investors should review. Among 956 Drug Manufacturers companies, Cantourage Group SE ranks worse than 53.66% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Cantourage Group SE's Net Income for the six months ended in Jun. 2025 was €0.04 Mil. Cantourage Group SE's Revenue for the six months ended in Jun. 2025 was €0.82 Mil. Therefore, Cantourage Group SE's net margin for the quarter that ended in Jun. 2025 was 4.37%.

The historical rank and industry rank for Cantourage Group SE's Net Margin % or its related term are showing as below:

XTER:HIGH' s Net Margin % Range Over the Past 10 Years
Min: -110.75   Med: -18.36   Max: 4.37
Current: 4.37

XTER:HIGH's Net Margin % is ranked worse than
53.66% of 956 companies
in the Drug Manufacturers industry
Industry Median: 5.56 vs XTER:HIGH: 4.37

Cantourage Group SE  (XTER:HIGH) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Cantourage Group SE Net Margin % Related Terms

Cantourage Group SE Net Margin % Historical Data

* Premium members only.

The historical data trend for Cantourage Group SE's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cantourage Group SE Net Margin % Chart

Cantourage Group SE Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
0.00 -110.75 -18.58 1.49 -18.14

Cantourage Group SE Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Jun25
Net Margin % Get a 7-Day Free Trial Premium Member Only 2.65 4.84 -18.73 23.50 4.37

XTER:HIGH vs ZTS, UTHR, VTRS: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Cantourage Group SE's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cantourage Group SE Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cantourage Group SE's Net Margin % distribution charts can be found below:

* The bar in red indicates where Cantourage Group SE's Net Margin % falls into.


XTER:HIGH
22GF Score
Cantourage Group SE XTER:HIGH
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cantourage Group SE Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Cantourage Group SE's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-4.273/23.557
=-18.14 %

Cantourage Group SE's Net Margin for the quarter that ended in Jun. 2025 is calculated as

Net Margin=Net Income (Q: Jun. 2025 )/Revenue (Q: Jun. 2025 )
=0.036/0.823
=4.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 4.37% mean?
Cantourage Group SE (XTER:HIGH) has a Net Margin % of 4.37% as of Jun. 2025. Net margin is the ratio of total net income to net sales. View historical data on Cantourage Group SE and its competitors. According to the industry distribution chart, Cantourage Group SE ranks #513 out of 956 companies in the Drug Manufacturers industry, placing it in the top 53.7%.
Is Cantourage Group SE's Net Margin % too high?
Cantourage Group SE's current Net Margin % is 4.37%. The Drug Manufacturers industry median Net Margin % is 5.56. Cantourage Group SE's value of 4.37% is 21.4% below this industry median. Based on the distribution chart, Cantourage Group SE ranks #513 out of 956 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Cantourage Group SE has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Cantourage Group SE's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Cantourage Group SE ranks #513 out of 956 companies for Net Margin %. This places Cantourage Group SE in the lower half of its industry. The industry median Net Margin % is 5.56. Cantourage Group SE's value of 4.37% is 21.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cantourage Group SE's current Net Margin % of 4.37% is 21.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Cantourage Group SE and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cantourage Group SE's current Net Margin % is 4.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cantourage Group SE stock overvalued right now?
Cantourage Group SE (XTER:HIGH) has a current Net Margin % of 4.37%. The current Net Margin % is 4.37% and 21.4% below the Drug Manufacturers industry median of 5.56. Cantourage Group SE's overall GF Score™ is 22/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Cantourage Group SE (XTER:HIGH), the current Net Margin % is 4.37% as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cantourage Group SE Business Description

Address Feurigstrasse 54, Berlin, DEU, 10827
Cantourage Group SE is engaged in the manufacture and wholesale of medicinal preparations based on cannabis and the trade and distribution of other legally permissible cannabis products, medical devices, pharmaceuticals, and accessories. The group offers cannabis flowers, dronabinol, CBD, and extracts of various strains.
22GF Score

Get the complete analysis for XTER:HIGH

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.04
Price